US Stock MarketDetailed Quotes
EMBC Embecta
- 10.890
- +0.010+0.09%
Close Apr 24 16:00 ET
- 10.890
- 0.0000.00%
Post 16:02 ET
627.03MMarket Cap11.34P/E (TTM)
10.915High10.710Low284.24KVolume10.770Open10.880Pre Close3.08MTurnover0.53%Turnover Ratio8.93P/E (Static)57.58MShares30.97752wk High-0.79P/B579.50MFloat Cap9.92552wk Low0.60Dividend TTM53.21MShs Float46.720Historical High5.51%Div YieldTTM1.88%Amplitude9.925Historical Low10.847Avg Price1Lot Size
About Embecta Company
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Company Profile
SymbolEMBC
Company NameEmbecta
Listing DateMar 22, 2022
Founded1924
CEOMr. Devdatt Kurdikar
MarketNASDAQ
Employees2200
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address300 Kimball Drive,Suite 300
CityParsippany
ProvinceNew Jersey
CountryUnited States of America
Zip Code07417-07054
Phone1-862-401-0000
Websitehttp://www.embecta.com
Company Executives
- Name
- Position
- Salary
- Devdatt Kurdikar
- Director, President and Chief Executive Officer
- 7.46M
- Colleen Riley
- Senior Vice President and Chief Technology Officer
- --
- Jean M. Casner
- Senior Vice President and Chief Human Resources Officer
- --
- Jacob Elguicze
- Senior Vice President and Chief Financial Officer
- 2.58M
- Brian R. Capone
- Vice President, Chief Accounting Officer and Corporate Controller
- 908.94K
- Ginny Blocki
- Senior Vice President, Product Management and Global Marketing
- --
- Shaun Curtis
- Senior Vice President, Global Manufacturing and Supply Chain
- 1.49M
- Jeffrey Z. Mann
- Senior Vice President, General Counsel, Head of Corporate Development and Corporate Secretary
- 2.20M
- Tom Blount
- Senior Vice President and President, North America
- --
- Slobodan Radumilo
- Senior Vice President and President, International
- --
- General David F. Melcher
- Non-Executive Chairman of the Board
- 459.97K
- Carrie L. Anderson
- Independent Director
- 272.02K
- David J. Albritton
- Independent Director
- 272.27K
- Karen N. Prange
- Independent Director
- 288.02K
- Robert J. Hombach
- Independent Director
- 288.02K
- Dr. Claire Pomeroy, M.B.A.,M.D.
- Independent Director
- 293.02K
- Christopher R. Reidy
- Independent Director
- 288.02K
- Dr. Milton M. Morris,PhD
- Independent Director
- 277.02K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg